The impact of hyperbaric oxygen therapy on serological values of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)
2010

Effects of Hyperbaric Oxygen Therapy on Growth Factors

Sample size: 43 publication Evidence: moderate

Author Information

Author(s): Jung Susanne, Wermker Kai, Poetschik Harald, Ziebura Thomas, Kleinheinz Johannes

Primary Institution: University Hospital Muenster

Hypothesis

What is the impact of hyperbaric oxygen therapy on the levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with sudden sensorineural hearing loss or tinnitus?

Conclusion

The study found no significant effect of hyperbaric oxygen therapy on serum concentrations of bFGF and VEGF.

Supporting Evidence

  • There was no significant change in VEGF concentration during HBO therapy.
  • Women showed significantly higher levels of VEGF compared to men.
  • A significant reduction of bFGF was detected under HBO therapy.

Takeaway

Hyperbaric oxygen therapy didn't change the levels of certain growth factors in patients with hearing loss or tinnitus.

Methodology

Forty-three patients received 10 sessions of hyperbaric oxygen therapy, and their serum levels of bFGF and VEGF were measured at various intervals.

Limitations

The study's findings may not apply to other conditions outside of sudden sensorineural hearing loss or tinnitus.

Participant Demographics

43 patients, 22 males and 21 females, aged 16-62 years.

Statistical Information

P-Value

0.041 for bFGF, 0.015 for VEGF

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1746-160X-6-29

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication